Your browser doesn't support javascript.
loading
The role of genomic disorders in chronic kidney failure of undetermined aetiology ≤50 years.
Granhøj, Jeff; Pedersen, Katja Venborg; Aagaard, Mads Malik; Graakjaer, Jesper Aagaard; Lildballe, Dorte Launholt; Birn, Henrik; Rasmussen, Maria.
Afiliação
  • Granhøj J; Department of Clinical Genetics, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark.
  • Pedersen KV; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Aagaard MM; Department of Clinical Genetics, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark.
  • Graakjaer JA; Department of Clinical Genetics, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark.
  • Lildballe DL; Department of Clinical Genetics, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark.
  • Birn H; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Rasmussen M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Clin Kidney J ; 17(7): sfae166, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39021813
ABSTRACT

Background:

Genomic disorders caused by copy number variations (CNVs) are prevalent in patients with kidney disease; however, their contribution to chronic kidney failure (KF) of undetermined aetiology (uKF) is unclear. We screened patients with uKF aged 50 years or younger to establish the prevalence of causative CNVs.

Methods:

We enrolled patients with an onset of KF ≤50 years from suspected undetermined aetiology for initial review of medical records to exclude patients with clear-cut clinical or histopathological kidney diagnoses or patients with already established genetic kidney diseases. Next, we performed single nucleotide polymorphism (SNP) array-based CNV screening. All the detected CNVs were systematically classified and evaluated as possible causes of the patient's kidney disease. Patients with CNVs not explaining the kidney phenotype were additionally screened for causal variants in 540 genes using whole-genome sequencing.

Results:

We enrolled 172 patients, of whom 123 underwent SNP-array. Pathogenic CNVs corresponding to known genomic disorders were identified in 12 patients (9.8%). The identified genomic disorders provided a causative kidney diagnosis in three patients, all of whom had reached KF by age 18 years. The remaining nine patients had CNVs with unclear kidney disease causality. Subsequently, whole-genome sequencing provided a causative genetic diagnosis in an additional four patients, including two diagnostic sequence variants unrelated to the detected CNVs.

Conclusions:

Genomic disorders were prevalent in this cohort with uKF, and causative CNVs were identified in 5 of 123 patients. Further studies combining the analysis of CNVs and sequence variants are needed to clarify the causal role of genomic disorders in kidney disease.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Kidney J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Kidney J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca